Preview Company (Stock code) Date/time Event Presenter
Summit Therapeutics - Initial trials of ridinilazole
SUMMIT THERAPEUTICS (SUMM) Thu, 10 Mar 2016 12:05 pm (UK time) Summit Therapeutics - Initial trials of ridinilazole Mark Wilcox - Professor
Summit Therapeutics - C. difficile Infection, a Recurring Problem
SUMMIT THERAPEUTICS (SUMM) Thu, 10 Mar 2016 12:00 pm (UK time) Summit Therapeutics - C. difficile Infection, a Recurring Problem Mark Wilcox - Professor
Summit Therapeutics - Master Investor 2015
SUMMIT THERAPEUTICS (SUMM) Wed, 29 Apr 2015 11:30 am (UK time) Summit Therapeutics - Master Investor 2015 Richard Pye, Head of Investor Relations - Richard Pye, Head of Investor Relations
Summit Corporation - Phase 1b clinical trial in DMD patients
SUMMIT THERAPEUTICS (SUMM) Fri, 23 May 2014 05:40 am (UK time) Summit Corporation - Phase 1b clinical trial in DMD patients Glyn Edwards - CEO